About Us

To celebrate our achievement of surviving and thriving for over 5 years the three of us have chosen to set up a charity – The Three Tumours.  All three of us are from the North East but would probably never have become friends if it wasn’t for the challenges that unite us….

Who we are

Find out more about who we are, where we have come from and where we want to take the charity.

Our strategy

Read up on our strategy of how we want to grow the charity.

 
Background
  • In the UK, 16,000 people each year are diagnosed with a brain tumour.
  • Less than 20% of brain tumour patients survive beyond five years of their diagnosis, whereas 86% of breast cancer and 51% of leukaemia patients survive beyond five years.
  • Those with a GBM4, the most common Brain Tumour, have an even worse prognosis – an average life expectancy of 12-18 months with treatment.
  • Brain tumours are the chief cause of cancer deaths in children and young people. In 2015, the number of children dying from cancer was 194, with brain tumours taking 67 young lives and leukaemia 46.
  • Brain tumours continue to kill more children and adults under the age of 40 than any other cancer. Brain tumours deaths are rising, representing 2.6% of all deaths from cancer. They kill more children than leukaemia, more men under 45 than prostate cancer and more women under 35 than breast cancer.
  • Incidences of and deaths from brain tumours are increasing.
  • In 2015, £8,759 was spent on leukaemia research for each death, compared with only £1,858 for brain tumours. Brain tumour research represents just 1.37% of national spend on cancer.
  • Awareness of the devastation caused by brain tumours is low. Less than 10% of people in the UK know that brain tumours kill more children and adults under the age of 40 than any other cancer.[3]
(In)effectiveness of Treatment
  • Unfortunately, glioblastomas are aggressive tumours and often appear resistant to treatment. This is probably because the cells within the tumour are not all of the same type. This is known as ‘heterogeneity‘. This means that certain treatments will kill off certain types of glioblastoma cell but leave the others.[4]
  • At the current rate of spend, it could take 100 years for brain cancer to catch up with developments in other diseases and find a cure.[5]

[1] Chandler, L., Prados, M. D., Malec, M., & Wilson, C. B. (1993). Long-term survival in patients with glioblastoma multiforme. Neurosurgery, 32(5): 716-720

[2] Glioblastoma multiforme – Glioblastoma, also known as glioblastoma multiforme, GBM or grade IV astrocytoma, is a fast-growing, aggressive type of central nervous system tumour that forms on the supportive tissue of the brain. Glioblastoma is the most common grade IV brain cancer. Source: 08/02/18 https://www.cancercenter.com/brain-cancer/types/tab/glioblastoma-multiforme/

[3] https://www.braintumourresearch.org/campaigning/stark-facts

[4] https://www.thebraintumourcharity.org/understanding-brain-tumours/types-of-brain-tumour-adult/glioblastoma/

[5] Ibid 3